Independent information. England-wide.Public data. Clear sources.

NCT06843447

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

Registered research study with 6 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Ovarian Cancer Recurrent
Lead sponsor
Merck Sharp & Dohme LLC
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
18 Years to Not specified
Sex eligibility field
Female
Healthy volunteers accepted
No, according to the record
Phase
Phase1, Phase2
Study record last updated
2 September 2026
Study team last verified status
2026-08

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
University Hospitals Sussex NHS Foundation Trust ( Site 0404)

Brighton · BN2 1ES

RecruitingCare in The City of Brighton and Hove

England postcode

Royal Marsden Hospital ( Site 0402)

Fulham · SW3 6JJ

RecruitingCare in Kensington and Chelsea

England postcode

The Royal Marsden NHS Foundation Trust. ( Site 0403)

Sutton · SM2 5PT

RecruitingCare in Sutton

England postcode

Barts Health NHS Trust ( Site 0401)

London · E1 1RD

RecruitingCare in Tower Hamlets

England postcode

Guy s & St Thomas NHS Foundation Trust ( Site 0400)

London · SE1 3SS

RecruitingCare in Southwark

England postcode

The Christie NHS Foundation Trust ( Site 0405)

Manchester · M20 4BX

RecruitingCare in Manchester

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.